Keeping Track: Amgen Parsabiv Is Latest To Receive Complete Response; Pfizer Troxyca ER Finally Approved; Remune Returns

 
• By Bridget Silverman

The latest drug development news and highlights from our FDA Performance Tracker.

More from United States

More from North America